| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939821A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 09/08/1999 | EP0939819A1 Mini-e1a genes and gene products |
| 09/08/1999 | EP0939818A1 Recombinant toxin fragments |
| 09/08/1999 | EP0939816A1 Circularly permuted erythropoietin receptor agonists |
| 09/08/1999 | EP0939814A1 Fringe proteins and notch signalling |
| 09/08/1999 | EP0939812A2 Novel human macrophage antigen |
| 09/08/1999 | EP0939807A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939806A1 Fanconi gene 1 |
| 09/08/1999 | EP0939805A2 Secreted proteins and polynucleotides encoding them |
| 09/08/1999 | EP0939804A1 NEUTROKINE alpha |
| 09/08/1999 | EP0939802A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 09/08/1999 | EP0939656A1 Gene delivery and expression in areas inaccessible to direct protein delivery |
| 09/08/1999 | EP0939655A1 Stable protein and nucleic acid formulations using non-aqueous, anhydrous, aprotic, hydrophobic, non-polar vehicles with low reactivity |
| 09/08/1999 | EP0939646A2 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 09/08/1999 | EP0939642A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 09/08/1999 | EP0939623A1 Oral delayed immediate release formulation and method of preparation therefor |
| 09/08/1999 | EP0939621A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 09/08/1999 | EP0939590A1 Delivery of therapeutic gene products by intestinal cell expression |
| 09/08/1999 | EP0927044A4 Targeted viral vectors |
| 09/08/1999 | EP0871463A4 Regulation of eating behavior |
| 09/08/1999 | CN1228018A Liposomal compositions and method of using them |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948902 Antisense oligonucleotides to human serine/threonine protein phosphatase genes |
| 09/07/1999 | US5948901 Antisense oligonucleotides for aromatase inhibition |
| 09/07/1999 | US5948898 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression |
| 09/07/1999 | US5948878 Copolymerization of a diprimary amine and other comonomer |
| 09/07/1999 | US5948767 Transport of active material into cells; drug delivery |
| 09/07/1999 | US5948675 Host-vector system which can be used in gene therapy |
| 09/07/1999 | US5948669 As probes and primers; for diagnosis and treatment of osteoporosis, oral diseases, paget's disease; antiarthritic agents, anticarcinogenic/antitumor/antimetastasis agents |
| 09/07/1999 | US5948657 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 09/07/1999 | US5948653 Sequence alterations using homologous recombination |
| 09/07/1999 | US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome |
| 09/07/1999 | US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor |
| 09/07/1999 | US5948638 TNF receptor death domain ligand proteins |
| 09/07/1999 | US5948626 Method of detecting human phospholipase inhibitor |
| 09/07/1999 | US5948435 Methods of regulating CETP genes, enzymes and other compound, and pharmaceutical composition therefor |
| 09/05/1999 | CA2264431A1 Canine factor viii gene, protein and methods of use |
| 09/02/1999 | WO1999043842A1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus |
| 09/02/1999 | WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | WO1999043832A2 Human proteinase molecules |
| 09/02/1999 | WO1999043831A1 Cprot03, a human cysteine protease |
| 09/02/1999 | WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | WO1999043812A2 Dlc-1 gene, a putative tumors suppressor gene |
| 09/02/1999 | WO1999043795A1 Trans-somatics with gene transfer into mammary epithelial cells |
| 09/02/1999 | WO1999043789A1 Efficient aav vectors |
| 09/02/1999 | WO1999043752A1 Compositions for transporting negatively charged substances |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043692A1 pyrH GENE AND PROTEIN OF STREPTOCOCCUS PNEUMONIAE |
| 09/02/1999 | WO1999043360A1 Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex |
| 09/02/1999 | WO1999043346A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | WO1999043208A1 The helios gene |
| 09/02/1999 | WO1999031240A3 14-3-3σ ARRESTS THE CELL CYCLE |
| 09/02/1999 | WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth |
| 09/02/1999 | WO1999020766A3 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2322160A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321959A1 Methods for diagnosing and treating autoimmune disease |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321200A1 Composition for transporting negatively charged substances |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939123A2 Estrogen receptor-related polypetide SBPERR4 |
| 09/01/1999 | EP0938904A1 Mammalian cell transduction for use in gene therapy |
| 09/01/1999 | EP0938580A1 Artificial polymeric membrane structure, method for preparing same, method for preparing this polymer, particle and film containing this structure |
| 09/01/1999 | EP0938579A1 Improved adenovirus vectors generated from helper viruses and helper-dependent vectors |
| 09/01/1999 | EP0938578A1 Genetic modification of primate hemopoietic repopulating stem cells |
| 09/01/1999 | EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
| 09/01/1999 | EP0938561A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 09/01/1999 | EP0938559A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR |
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
| 09/01/1999 | EP0938553A1 Dna encoding dp. 75 and a process for its use |
| 09/01/1999 | EP0938343A2 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 09/01/1999 | EP0938341A2 Compositions and methods for altering the biodistribution of biological agents |
| 09/01/1999 | EP0938337A1 Chimeric kanamycin resistance gene |
| 09/01/1999 | EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof |
| 09/01/1999 | EP0938298A1 Liposomes |
| 09/01/1999 | EP0752882A4 Treatment for juvenile diabetes |
| 09/01/1999 | EP0723455A4 Methods of inhibiting phagocytosis |
| 09/01/1999 | CN1227611A Isolated nucleic acid molecules which are members of the MAGE-B family and use thereof |
| 09/01/1999 | CN1227496A Screening method for compounds useful in the regulation of body weight |
| 08/31/1999 | US5945505 Human phospholemman-like protein |
| 08/31/1999 | US5945452 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| 08/31/1999 | US5945403 Angiostatin fragments and method of use |
| 08/31/1999 | US5945400 Nucleic acid-containing composition, preparation and use thereof |
| 08/31/1999 | US5945335 A nucleic acid molecule that functions as an accessory molecule for recombinant adeno-associated virus particle production; gene therapy for diabetes and hemophilia and anticarcinogenic agent |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945300 Polypeptides with dna(rna) encoding and genetic engineering |
| 08/31/1999 | US5945100 Tumor delivery vehicles |
| 08/31/1999 | CA2004364C Antisense oligonucleotides to c-myb oncogene and uses thereof |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |